常茂生物中期报告 2023

ͦ፽ 2 26 1 HH 1228213034 2 34 2.1 3 4 5 8 877,659,000820,055,000 9 10 15%25% 11 4,157,00040,880,000529,700,000529,700,000 12 13 14 (a) 2,500,000343,500,000183,700,000HHHH 71,976,00072,729,000 4.3%4.3%3.5%3.6% 21 22 296,608,000382,810,00023%4,157,00040,880,00090% (1.)(2.)(3.) 23% PQQ.Na2 (1) PQQ.Na2 (2) (1) (2) (3) (4) (5)A AAAA 26%35%74%65% 413,643,000289,615,00019 48,328,000 1941.9%35.5%100,132,00059,993,000 57447946,082,00042,387,00040,000,000 (a)5% (b)5%(c)5% 4,000,000 22 XV(a)XV78(b)352(c)(d)622 (a)96,500A135,000,000170,000A100,000B70%2,500,0003,768,000H52,000H(b) (b)73,500A53,000B135,000,000170,000A100,000B30%2,500,00052,000H3,768,000H(a) (c)2,000B135,000,000170,000A100,000B200,00067,500,0006,750,000 (d)380,00067,500,0006,750,0002,000B135,000,000170,000A100,000B (e)66,000,0002,620,000H (f)220,00067,500,0006,750,000 ᛆू מᚣ (g)800B135,000,000170,000A100,000B120,00067,500,0006,750,000 (h)2,500,000 (i)343,500,000 (j)183,700,000H XV(a)XV78(b)352(c)(d)622 XV23 XV23336 (a)66,000,0002,620,000H (b)100%62,500,000 (c)62.3%100%62,500,000 (d)100%62.3%100%62,500,000 (e)343,500,000 (f)183,700,000H XV23336 529,700,000 (a)0.10 (b)0.10 (c)0.10 HH H (a) (b) (c) (d) ൚ค H ൚ค